Lawmakers question ads for Bayer “herbal” aspirin

By Susan Heavey

WASHINGTON (Reuters) - Democratic lawmakers are expanding a probe into direct-to-consumer drug advertisements to include Bayer AG’s combination aspirin product, according to letters released on Tuesday.

Bayer’s marketing of its Aspirin with Heart Advantage, a combination product that includes a dietary supplement, appears to go against a U.S. Food and Drug Administration request not to advertise such products, said House of Representatives Energy and Commerce Chairman John Dingell.

Advertising the product to consumers “may mislead the public,” Dingell wrote along with Oversight and Investigations Subcommittee Chairman Rep. Bart Stupak.

“The FDA strongly recommends that firms refrain from marketing products that combine or co-package drug and dietary supplement ingredients,” but would be willing to review them for possible approval, then-Associate Commissioner for Policy Margaret Dotzel said in May 2000.

While aspirin is FDA-approved, dietary supplements such as vitamins and herbs are not subject to agency scrutiny before marketing.

In the letter to Bayer, HealthCare President Gary Balkema, Michigan Democrats Dingell and Stupak asked whether the company planned to seek FDA approval for the combination product. They also called on the company to provide lawmakers with all related records within two weeks.

“The Committee is concerned that your company engaged in DTC (direct-to-consumer) advertising of this product, particularly in light of FDA’s recommendation to refrain from marketing combination products,” they wrote.

Bayer, in a statement, said its advertisements tell consumers to consult their doctors before using Bayer Aspirin with Heart Advantage and warns it does not replace cholesterol medications. The drugmaker added it was reviewing the lawmakers’ letter.  Continued…


Related Posts:

By Lisa Richwine WASHINGTON (Reuters) - A key Democrat made a renewed call on Monday for giving regulators the power to ban advertisements to consumers when a new medicine first reaches the market and risks are not fully known. Rep. Henry Waxman listed the idea as one of many he would like to pursue as chairman of

Full Post: Democrat backs advertising limits for medicines

Review Summary This dietary supplement is manufactured and promoted by a company known as ALRI. Interestingly enough, this product is promoted as a supplement that is, as one sources states, designed for adults age 21 and over. The need for an age limit for users of this product is not explained, but we feel it is

Full Post: Venom Hyperdrive 3.0 and Its Advertised Weight Loss Benefits

Review Summary This product is a dietary supplement promoted by a Dr. Henry Lewis. Currently, there is very little information about this supplement posted online, as most of its advertisements are sent to dieters in bulk mail. We do know that this product promises fast and easy weight loss and even claims that dieters can lose

Full Post: Fat Killer - Can This Diet Pill Live Up to Its Own Name?

CHICAGO (Reuters) - Airborne Health Inc has agreed to pay $7 million to settle investigations by 32 state attorneys general and the District of Columbia over the past marketing and labeling of its products. Airborne did not admit any wrongdoing in the settlement. It previously settled two matters involving similar claims. The privately held company makes popular

Full Post: Airborne pays $7 mln in settlement with 32 states

Review Summary To put it simply, this company is a brand of dietary supplements, most of which are advertised to lead to weight loss. In fact, this company claims to be the weight loss and wellness leader since 1992. When it comes to their weight loss aids, this company appears to promote products that contain trendy

Full Post: Fit America - Diet Products For Weight Loss

Site Navigation

Most Read